Vafseo® (vadadustat) Dialysis Dependent Patient Post Hoc Data Analysis: Composite of All-Cause Mortality and Hospitalization Outcomes Statistically More Favorable for Patients Receiving Vadadustat vs. ESAs

Seeking Alpha / 1 Views

Win-Odds Analysis Presented at American Society of Nephrology Kidney Week 2025
Win-Odds Analysis Presented at American Society of Nephrology Kidney Week 2025

Comments